|
Geovax Labs, Inc. (Govx) Avaliação DCF
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
GeoVax Labs, Inc. (GOVX) Bundle
Otimize seu tempo e melhore a precisão com a nossa calculadora DCF (Govx)! Equipado com dados reais da Geovax Labs, Inc. e suposições personalizáveis, essa ferramenta permite que você preveja, analise e valorize o Geovax como um investidor experiente.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.2 | 1.8 | .4 | .1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | 55.03 | -78.88 | -78.96 | -100 | -50.7 | -50.7 | -50.7 | -50.7 | -50.7 |
| EBITDA | -2.4 | -2.8 | -18.5 | -14.0 | -26.7 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -200.51 | -153.31 | -4813.12 | -17249.73 | 100 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | .0 | .0 | .0 | .1 | .1 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 0.7101 | 1.08 | 10.01 | 69.49 | 100 | 36.26 | 36.26 | 36.26 | 36.26 | 36.26 |
| EBIT | -2.4 | -2.8 | -18.6 | -14.0 | -26.7 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -201.22 | -154.39 | -4823.12 | -17319.21 | 100 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | .3 | 9.9 | 11.4 | 27.6 | 6.5 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 5.83 | 10.02 | 12.73 | 0 | 100 | 25.72 | 25.72 | 25.72 | 25.72 | 25.72 |
| Inventories | .0 | -.2 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | -10.02 | -12.73 | 0 | 100 | 15.45 | 15.45 | 15.45 | 15.45 | 15.45 |
| Accounts Payable | .2 | .3 | 2.1 | 1.7 | 2.8 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 12.98 | 14.68 | 534.42 | 2157.63 | 100 | 65.53 | 65.53 | 65.53 | 65.53 | 65.53 |
| Capital Expenditure | .0 | -.2 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -0.64683 | -8.6 | -12.39 | -165.75 | 100 | -24.33 | -24.33 | -24.33 | -24.33 | -24.33 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -2.4 | -2.8 | -18.5 | -14.0 | -26.7 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -2.3 | -2.7 | -16.7 | -14.4 | -25.7 | -2.8 | .0 | .0 | .0 | .0 |
| WACC, % | 19.54 | 19.54 | 19.54 | 19.54 | 19.54 | 19.54 | 19.54 | 19.54 | 19.54 | 19.54 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -2.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | -2 | |||||||||
| Net Debt | -6 | |||||||||
| Equity Value | 4 | |||||||||
| Diluted Shares Outstanding, MM | 3 | |||||||||
| Equity Value Per Share | 1.62 |
What You Will Get
- Genuine GeoVax Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures for GeoVax Labs, Inc. (GOVX).
- Comprehensive Customization: Modify all key parameters (yellow cells) such as WACC, growth %, and tax rates to fit your analysis.
- Immediate Valuation Updates: Automatic recalculations to assess the impact of changes on GeoVax's fair value.
- Flexible Excel Template: Designed for quick edits, scenario testing, and in-depth projections tailored to GeoVax Labs, Inc. (GOVX).
- Efficient and Precise: Avoid the hassle of building models from scratch while ensuring accuracy and adaptability.
Key Features
- Comprehensive Data: GeoVax's historical financial statements and pre-filled projections.
- Customizable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Real-Time Results: View GeoVax's intrinsic value recalculated instantly.
- Intuitive Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
- Designed for Precision: A professional-grade tool for analysts, investors, and finance professionals.
How It Works
- Step 1: Download the Excel file.
- Step 2: Examine GeoVax Labs, Inc.'s pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
- Step 5: Evaluate the outputs and leverage the results for investment strategies.
Why Choose This Calculator for GeoVax Labs, Inc. (GOVX)?
- Accurate Data: Up-to-date GeoVax financials provide dependable valuation outcomes.
- Customizable: Modify essential parameters like growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations save you the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate interface and detailed instructions make it accessible for everyone.
Who Should Use This Product?
- Investors: Accurately assess GeoVax Labs, Inc.’s (GOVX) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis specific to the biotech industry.
- Consultants: Efficiently modify the template for valuation reports tailored to clients in the healthcare sector.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading biotech firms.
- Educators: Implement it as a teaching resource to illustrate valuation techniques in biotechnology.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for GeoVax Labs, Inc. (GOVX).
- Real-World Data: GeoVax Labs’ historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for deeper insights into GeoVax Labs’ performance.
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to GeoVax Labs, Inc. (GOVX).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to GeoVax Labs, Inc. (GOVX).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.